View jnj business summary and other industry information. Shares have lost about 0.1% in that time frame, underperforming the S&P 500. How volatile is . It's a foregone conclusion that J&J's current top-selling drug, Remicade, will continue to lose market share due to biosimilar competition. Johnson & Johnson’s share of the baby care market worldwide is expected to gradually decline in the coming years to hit a low of 17.9 percent in 2021, a decrease of almost eight percent since 2013. However, the … Johnson & Johnson is a multinational medical devices and pharmaceutical company. Johnson And Johnson's competitive profile, comparisons of quarterly results to its competitors, by sales, income, profitability, market share by products and services - CSIMarket How has Johnson & Johnson's share price performed over time and what events caused price changes? Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. 03/13: JOHNSON & JOHNSON: Announces Collaboration with the Beth Israel Deaconess Medical Center to Accelerate COVID-19 Vaccine Development J & J is an American multinational pharmaceutical, medical equipment, & consumer goods company. Johnson & Johnson company facts, information and stock details by MarketWatch. As for its global pharmaceutical business, Johnson & Johnson develops and sells some of the best-known over-the-counter drugs on the market. Johnson & Johnson company facts, information and stock details by MarketWatch. 03/13: JOHNSON & JOHNSON: Announces Collaboration with the Beth Israel Deaconess Medical Center to Accelerate COVID-19 Vaccine Development Dev. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Johnson & Johnson Common Stock (JNJ) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Share this with Facebook ... Oklahoma settled with OxyContin maker Purdue Pharma for $270m and Teva Pharmaceutical for $85m, leaving Johnson & Johnson … Its primary focus is … This article lists the top 12 Johnson & Johnson competitors. Will … NEW BRUNSWICK, N.J., May 15, 2019 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will host a meeting today with industry analysts to review the strategy of its Janssen Pharmaceutical Companies to deliver above-market, compound annual growth through 2023. The company will also discuss its progress across its six therapeutic areas, pipeline developments and capital allocation framework. In the blue circle, you can see that the stock fell below $120 per share, which it hasn’t reached since. Johnson And Johnsons' competitors and its Market Share by PROCRIT, RISPERDAL, REMICADE, LEVAQUIN / FLOXIN, Other, Total Consumer, Med. Johnson & Johnson's share price compared to the market and industry in the last 5 years? Shares of Johnson & Johnson rose more than 1.8% in early trading Tuesday, implying that the company could grow by more than $6 billion in market cap. Find the latest Johnson & Johnson (JNJ) stock quote, history, news and other vital information to help you with your stock trading and investing. Shares of Johnson & Johnson rose more than 1.8% in early trading Tuesday, implying that the company could grow by more than $6 billion in market cap.